We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam Grants Qiagen License to Kreutzer-Limmer Patents

News   Sep 22, 2005

 
Alnylam Grants Qiagen License to Kreutzer-Limmer Patents
 
 
 

RELATED ARTICLES

Gene Linked to Impaired Memory in Down Syndrome – A Potential Drug Target?

News

It may one day be possible to reverse abnormal embryonic brain development linked to Down syndrome (DS) and improve cognitive function by therapeutically targeting a key gene known as OLIG2 prenatally, suggests newly published findings.

READ MORE

Discovery of Novel Genes May Lead to New Therapies for Muscle Cancer

News

Scientists have uncovered a unique set of genes that play a role in muscle cellular gene expression and differentiation which could lead to new therapeutic targets to prevent the spread of muscle cancer.

READ MORE

Bacterial Cell Division Drives Size Homeostasis

News

Working with bacteria, a multidisciplinary team at the University of California San Diego has provided new insight into a longstanding question in science: What are the underlying mechanisms that control the size of cells?

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE